Samsung's NeuroLogica unit snagged an FDA OK for its digital radiography system, giving the company a boost as it aims for a top spot in the medical device imaging market.
The devicemaker's GC85A ceiling digital X-ray system adds to its expanding suite of products, which includes its mobile digital GM60A, the U-arm digital GU60A and the ceiling digital GC80. The device includes wireless, lightweight detectors, a portable grid, and smart features that allow operators to position the entire system with one touch and work with compatible Samsung equipment, the company said in a statement.
"The Samsung GC85A represents NeuroLogica's latest commitment to introducing user- and patient-centric innovation to healthcare to provide fast, easy and accurate diagnoses," David Webster, NeuroLogica's chief marketing officer and VP of global sales, said in a statement. "The system's superior image quality and ease of control will enable users to experience a new level of efficiency with a DR system designed for streamlined operation."
The regulatory blessing adds fuel to Samsung's fire, helping it gain ground in medical imaging a few years after it acquired NeuroLogica to expand its presence in the industry. In 2013, the company snatched up NeuroLogica for an undisclosed sum to further its plans of becoming a leading medical device imaging player by 2020. Danvers, MA-based NeuroLogica's stand-out product is its BodyTom portable system, a full-body, 32-slice computed tomography (CT) scanner that can be rolled from room to room. With new technology in tow, Samsung is shooting for medical equipment product sales of around $10 billion by 2020.
And the company has not wasted any time chasing its lofty sales goals. In January 2014, NeuroLogica teamed up with device giant Stryker ($SYK) to sell a full-body portable CT scanner.
Samsung is also hard at work on the R&D front, announcing earlier this year that it would join forces with Harvard Medical School affiliate Partners HealthCare to develop digital and mobile software for health and wellness purposes. The collaboration could yield fruitful results further down the line, as Samsung builds out its portfolio and applies its technology on a broader scale.
- read Samsung's statement